Posts Tagged ‘MPOC’

Monday September 26th, 2016

Dr. Àlvar Agustí, chairman of the GOLD initiative for the diagnosis and treatment of COPD

Dr. Alvar Agustí, has been elected president of the Global Initiative for Chronic Obstructive Lung Disesase (GOLD) a global consensus about the strategy for the diagnosis, treatment and prevention of Chronic Obstructive Pulmonary Disease (COPD). Dr. Agustí is Director of the Institute Clínic Respiratory at Hospital Clínic de Barcelona, Head of the Inflammation and repair in respiratory illnesses IDIBAPS team, member of the Networked Biomedical Research Center for Respiratory Diseases (CIBERES) and president and founder of the Barcelona Respiratory Network (BRN).

Read the rest of this entry »

Comments Closed
Monday July 20th, 2015

The normal lung development in early childhood is crucial in preventing Chronic Obstructive Pulmonary Disease

A study published in the New England Journal of Medicine (NEJM) shows that abnormal lung development before 40 years of age predisposes to a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) 20 years later. Traditionally it was considered that COPD was a self-inflicted disease by smoking. This study shows that this is true in about half the cases but in the other half, abnormal lung development in the early years of life (and probably during pregnancy) is a very important risk factor. Dr. Àlvar Agustí, head of the Institute Clínic of Thorax at Hospital Clínic and of the IDIBAPS team  Inflammation and repair in respiratory illnesses, member of the Networked Biomedical Research Center for Respiratory Diseases (CIBERES) and founding president of the Barcelona Respiratory Network (BRN), is one of three co-directors of the study.

Read the rest of this entry »

Comments Closed
Wednesday September 10th, 2014

The use of inhaled corticosteroids does not prevent exacerbations in patients with advanced stable COPD

An international multicentre study published in the  New England Journal of Medicine showed that in patients with severe to very severe COPD, in stable clinical condition, inhaled corticosteroids can be stepwise withdrawn. The results have been presented on September the 8th at the European Congress of Pneumology, held in Munich. In this study has collaborated Dr. Roberto Rodríguez-Roisin, from the Pneumology Department at the Hospital Clínic of Barcelona.

Read the rest of this entry »

Comments Closed

Categories

Posted in:

Wednesday April 11th, 2012

COPD has no cure but patients live longer and better

Dr. Marc Miravitlles

The Seminars of The Lancet provide an updated view of significant pathologies. Recently Dr. Marc Miravitlles, from the IDIBAPS team Applied research in respiratory diseases, participated in a review devoted to chronic obstructive pulmonary disease (COPD), together with Marc Decramer and Wim Janssens from the University of Leuven (Belgium). The article reviews various aspects such as epidemiology, treatments and symptoms of the disease.

Read the rest of this entry »

Comments Closed
Monday February 28th, 2011

The Synergy-COPD project starts in Barcelona

mpoc

Barcelona Digital, technology centre specialized in the ICT research and development and TECNIO member -the ACC1Ó network that promotes the technology transfer and business innovation in Catalonia-, cellebrated last week the first meeting of R&D project Synergy-COPD. The project, made up by prestige partners from different European countries, will enable the creation of a more complet computer model of the COPD behavior (chronic obstructive pulmonary disease)

The meeting, held at the offices of Barcelona Digital in the Media-TIC building, welcomed experts internationally recognized as the Dr. Josep Roca of the Hospital Clínic, Dr. Dieter Maier of Biomax company, Dr. Jesper Tegnér of the Molecular Medicine Centre of the Karolinska Institute of Sweden, Dr. Luigi Ceccaroni of Barcelona Digital and the Dr. Peter Wagner of the Medicine School of the California University in San Diego.

Read the rest of this entry »

Comments Closed
Thursday August 13th, 2009

Non-invasive ventilation increases survival rate of chronic respiratory disease in ICU patients

This technique is easy to use in any ICU. The concerning paper proves it’s beneficial effects if applied immediately after extubation in patients suffering from chronic respiratory disease and high indicators of disease severity. Complications after extubation drop in over 30% of the cases and 90 days survival was increased in 20%. The conclusions of the study will cause the adaptation of the international clinical practice.

The Lancet is expected to publish the paper today, but it only will be available online. The conclusions of this review state that correct application of non-invasive ventilation after extubation increases survival of critical chronic respiratory patients in 20%. The study included 106 patients who were admitted in Hospital Clinic of Barcelona and it was performed by a group of investigators belonging to the Applied Research in Respiratory Infectious Diseases, Critical patients and Lung Cancer team, who were altogether lead by Dr. Miquel Ferrer and Dr. Antoni Torres, as Chief of Pneumology at the Hospital Clinic of Barcelona and project leader at the IDIBAPS. The outstanding results have definitely ended the controversy about the beneficial effects of non-invasive ventilation in these types of patients and it is most likely that future clinical practice around the world will be adjusted to the protocol described in this paper.

Read the rest of this entry »

Comments Closed